Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders

1. Front Matter

   Pages i-xiii

   PDF

2. Ocular Allergy

   • Andrea Leonardi, Neal P. Barney

   Pages 1-18

3. Immune Modulation in Ocular Mucous Membrane Pemphigoid

   • John Kenneth George Dart, Valerie P. J. Saw

   Pages 19-39

4. Diagnosis and Management of Scleritis

   • Claire Hooper, Peter McCluskey

   Pages 41-61

5. Noninfectious Inflammation in Cataract Surgery

   • Nick Mamalis, Stanley R. Fuller

   Pages 63-73

6. Corneal Inflammation Following Excimer Laser Surgery

   • Jaime Javaloy, Jorge L. Alió, Alfredo Vega Estrada

   Pages 75-94

7. Prevention and Treatment of Transplant Rejection in Keratoplasty

   • Uwe Pleyer, Anna-Karina Brigitte Maier

   Pages 95-116

8. Immunomodulation Against Inflammatory Postkeratoplasty Neovascularisation

   • Björn Bachmann, Claus Cursiefen

   Pages 117-121

9. Treatment of Inflammation Secondary to Vitreoretinal Surgery

   • Carolina Arruabarrena Sánchez, Marta S. Figueroa

   Pages 123-134

10. Treatment of Intermediate Uveitis

    • Elisabetta Miserocchi, Umberto De Benedetto, Giulio Modorati

    Pages 135-159

11. Posterior Uveitis

    • Piergiorgio Neri, Ilir Arapi, Uwe Pleyer, Moncef Khairallah, Soumyava Basu, Michele Nicolai et al.

    Pages 161-218

12. Cystoid Macular Edema

    • Marc D. de Smet

    Pages 219-230

13. Safety of Immunosuppressive Therapy for Eye Diseases

    • Dana M. Hornbeak, John H. Kempen

    Pages 231-244

These guidelines, compiled by a panel of clinicians and scientists with a high level of expertise, aim to provide readers with the most up-to-date and comprehensive instructions on the treatment and prevention of ocular inflammation. All of the recommendations are explicitly linked to supporting evidence and graded according to the strength of that evidence and the editors have made every effort to ensure that chapters are of a consistently high methodological quality. The guidelines for each treatment include dose and the frequency and mode of delivery. Significant side-effects of treatment are identified and distinguished from those of the disease in question. Suggestions are presented for the prevention both of the disease itself and of the treatment-related complications. In addition, likely future directions in treatment and prevention are identified. These guidelines will be of great practical value for all clinicians and clinical scientists with an interest in the subject.

• Evidence based medicine
• Immune modulatory agents
• Inflammatory diseases
• Ocular immunology
• Surgical approaches

• Department of Ophthalmology, Charité Campus Virchow-Klinikum, Berlin, Germany

  Uwe Pleyer

• Division of Ophthalmology, Miguel Hernandez University, Vissum-Instituto Oftalmologico de Alicante, Alicante, Spain

  Jorge L. Alió

• Centre of Ocular Inflammation and Infection OCUVAC, Medical University of Vienna Laura Bassi Centre of Expertise, Vienna, Austria

  Talin Barisani-Asenbauer

• Department of Ophthalmology, Pitié-Salpêtrière’s University Hospital, Paris, France

  Phuc Le Hoang

• Doheny Eye Institute, University of Southern California Keck School of Medicine, Los Angeles, USA

  Narsing A. Rao

Policies and ethics